成人与儿童功能性胃肠病中的肠道微生物组
综述总结肠道微生物组在功能性胃肠病(FGID)中的研究现状与未来方向。微生物组参与免疫发育、胃肠动力与分泌、上皮屏障完整性及脑-肠交流等生理过程,动物模型和人体研究提示其机制性作用;微生物组科学向临床转化仍处于起步阶段,但前景乐观。
要点
- 高通量测序使肠道微生物群落可作为整体研究,推动从关联分析走向机制研究。
- 肠道微生物组参与调节免疫发育、胃肠动力与分泌、上皮屏障完整性及脑-肠交流。
- 微生物组科学向临床转化仍处于起步阶段,作者对未来方向持乐观态度。
核心结论
- 肠道微生物组与功能性胃肠病的发病机制相关,但微生物组科学向临床的转化仍处于起步阶段。
- 作者认为该领域正朝着基于精确机制的微生物组治疗方向前进,前景乐观。
研究设计与样本
- 综述,聚焦功能性胃肠病中肠道微生物组研究的当前知识状态与未来方向。
主要发现
- 微生物组参与调节免疫发育、胃肠动力与分泌、上皮屏障完整性及脑-肠交流等生理过程。
- 综述汇总动物模型和人体研究数据,以说明微生物组介导生理过程改变的机制及其与人体干预的相关性。
- 综述总结了塑造人体肠道微生物组的因素。
- 微生物组科学向临床的转化仍处于起步阶段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The importance of gut microbiota in gastrointestinal (GI) physiology was well described, but our ability to study gut microbial ecosystems in their entirety was limited by culture-based methods prior to the sequencing revolution. The advent of high-throughput sequencing opened new avenues, allowing us to study gut microbial communities as an aggregate, independent of our ability to culture individual microbes. Early studies focused on association of changes in gut microbiota with different disease states, which was necessary to identify a potential role for microbes and generate novel hypotheses. Over the past few years the field has moved beyond associations to better understand the mechanistic implications of the microbiome in the pathophysiology of complex diseases. This movement also has resulted in a shift in our focus toward therapeutic strategies, which rely on better understanding the mediators of gut microbiota-host cross-talk. It is not surprising the gut microbiome has been implicated in the pathogenesis of functional gastrointestinal disorders given its role in modulating physiological processes such as immune development, GI motility and secretion, epithelial barrier integrity, and brain-gut communication. In this review, we focus on the current state of knowledge and future directions in microbiome research as it pertains to functional gastrointestinal disorders. We summarize the factors that help shape the gut microbiome in human beings. We discuss data from animal models and human studies to highlight existing paradigms regarding the mechanisms underlying microbiota-mediated alterations in physiological processes and their relevance in human interventions. While translation of microbiome science is still in its infancy, the outlook is optimistic and we are advancing in the right direction toward precise mechanism-based microbiota therapies.
引用
- Shin A, Preidis GA, Shulman R, et al. The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders. Clin Gastroenterol Hepatol. 2018. PMID: 30153517. doi:10.1016/j.cgh.2018.08.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。